Personalis, Inc. $PSNL Shares Sold by AIGH Capital Management LLC

Key Points

• AIGH Capital Management LLC cut its stake in Personalis by 25.5% in Q4, selling 992,101 shares and leaving it with 2.9 million shares (about 3.27% of Personalis), making PSNL its fourth-largest holding.
• Analyst sentiment is mixed-but-leaning-positive: five Buys, one Hold and one Sell result in a consensus rating of "Moderate Buy" with a consensus target price of $11.50, though recent targets and ratings have varied across firms.
• Fundamentals: PSNL trades near $5.78 with a $605M market cap and a one-year range of $3.84–$11.50; the company beat quarterly EPS estimates (-$0.26 vs. -$0.31) but remains unprofitable (net margin ~ -116.7%) and is forecast to post roughly -1.01 EPS for the year.

AIGH Capital Management LLC lowered its position in Personalis, Inc. (NASDAQ:PSNL - Free Report) by 25.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,900,000 shares of the company's stock after selling 992,101 shares during the period. Personalis comprises approximately 5.6% of AIGH Capital Management LLC's holdings, making the stock its 4th largest position. AIGH Capital Management LLC owned about 3.27% of Personalis worth $23,084,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Royal Bank of Canada lifted its position in shares of Personalis by 3.2% during the 1st quarter. Royal Bank of Canada now owns 78,341 shares of the company's stock valued at $275,000 after acquiring an additional 2,395 shares during the period. Howland Capital Management LLC lifted its position in shares of Personalis by 0.9% during the 2nd quarter. Howland Capital Management LLC now owns 285,308 shares of the company's stock valued at $1,872,000 after acquiring an additional 2,500 shares during the period. Legal & General Group Plc acquired a new stake in shares of Personalis during the 2nd quarter valued at approximately $30,000. BNP Paribas Financial Markets lifted its position in shares of Personalis by 406.4% during the 2nd quarter. BNP Paribas Financial Markets now owns 6,451 shares of the company's stock valued at $42,000 after acquiring an additional 5,177 shares during the period. Finally, Farther Finance Advisors LLC acquired a new stake in shares of Personalis during the 3rd quarter valued at approximately $66,000. Institutional investors and hedge funds own 61.91% of the company's stock.

Analyst Ratings Changes

A number of research firms have recently issued reports on PSNL. BTIG Research lifted their price target on shares of Personalis from $12.00 to $13.00 and gave the company a "buy" rating in a research report on Wednesday, February 11th. Needham & Company LLC lifted their price target on shares of Personalis from $10.00 to $12.00 and gave the company a "buy" rating in a research report on Friday, February 27th. Morgan Stanley cut their price objective on Personalis from $11.00 to $10.00 and set an "equal weight" rating for the company in a research report on Thursday, March 5th. Weiss Ratings restated a "sell (d-)" rating on shares of Personalis in a research report on Tuesday, April 21st. Finally, Guggenheim lifted their price objective on Personalis from $12.00 to $13.00 and gave the stock a "buy" rating in a research report on Monday, January 26th. Five analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Personalis presently has a consensus rating of "Moderate Buy" and a consensus target price of $11.50.

Personalis Stock Performance

PSNL stock opened at $5.78 on Friday. The stock has a market capitalization of $605.05 million, a P/E ratio of -6.35 and a beta of 1.96. Personalis, Inc. has a one year low of $3.84 and a one year high of $11.50. The company has a 50 day moving average price of $7.07 and a two-hundred day moving average price of $8.30.

Personalis (NASDAQ:PSNL - Get Free Report) last announced its quarterly earnings data on Thursday, February 26th. The company reported ($0.26) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.31) by $0.05. The company had revenue of $17.35 million during the quarter, compared to analysts' expectations of $17.12 million. Personalis had a negative net margin of 116.69% and a negative return on equity of 39.13%. Research analysts forecast that Personalis, Inc. will post -1.01 earnings per share for the current fiscal year.

Personalis Profile

Personalis, Inc NASDAQ: PSNL is a clinical‐stage genomics company that develops and markets advanced next‐generation sequencing (NGS) services and assays designed to accelerate precision medicine. The Company's core offering is the ImmunoID NeXT™ Platform, which combines comprehensive tumor profiling—including whole exome, transcriptome, and T‐cell receptor sequencing—with proprietary bioinformatics to identify biomarkers and guide immuno‐oncology research. Personalis serves biopharmaceutical companies, academic institutions, and clinical research organizations seeking in‐depth insights into cancer, autoimmune diseases and other complex conditions.

In addition to its flagship ImmunoID NeXT™ Platform, Personalis offers a suite of customizable sequencing assays for biomarker discovery, clinical trial support and companion diagnostic development.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.